Table 3: Postoperative complications 0-3 months postoperatively, in individuals alive at 3 months.
|
Postoperative complication, n (%), [95% C.I.] |
Study group |
Control group |
p-valuea) |
|
Endophthalmitis |
0 (0.00) [0.00, 0.08] |
0 (0.00) |
> 0.99 |
|
Postoperative CME - bilateral |
17 (0.36) [0.23, 0.58] 4 (0.08) |
11 (0.23) 4 (0.08) |
0.26 > 0.99 |
|
Persistent anterior uveitis - bilateral |
12 (0.25) [0.15, 0.45] 3 (0.06) |
14 (0.29) 2 (0.04) |
0.85 0.68 |
|
Retinal detachment - bilateral |
2 (0.04) [0.01, 0.15] 0 (0.00) |
2 (0.04) 1 (0.02) |
> 0.99 > 0.99 |
|
Corneal decompensation - bilateral |
0 (0.00) [0.00, 0.08] 0 (0.00) |
5 (0.10) 4 (0.08) |
0.06 0.13 |
|
Dry AMD progression to exudative AMD |
15 (0.32) [0.19, 0.53] |
21 (0.43) |
0.41 |
|
Malignant glaucoma |
0 (0.00) [0.00, 0.08] |
0 (0.00) |
> 0.99 |
|
|
|
|
|
|
Totally postoperative all complications, n (%) |
46 (0.98) |
53 (1.10) |
0.61 |
|
Without postoperative complications, n (%) |
4662 (99.02) |
4779 (98.90) |
0.61 |
|
Totally postoperative complications, AMD Excluded n (%) |
31 (0.66) |
32 (0.66) |
> 0.99 |
|
Without postoperative complications, AMD Excluded n (%) |
4677 (99.34) |
4800 (99.34) |
> 0.99 |
|
Patients died before the end of the follow up time, n (%) |
12 (0.51) |
11 (0.45) |
0.84 |
|
Operated eyes |
4708 |
4832 |
|
a) Fisher's exact test, AMD: Age Related Macular Degeneration; CME: Cystic Macular Edema; n = number of patients, 95% C.I.= 95% confidence interval,*= statistically significant